Cargando…

Development and Validation of an Algorithm to Identify Patients with Multiple Myeloma Using Administrative Claims Data

PURPOSE: The objective was to expand on prior work by developing and validating a new algorithm to identify multiple myeloma (MM) patients in administrative claims. METHODS: Two files were constructed to select MM cases from MarketScan Oncology Electronic Medical Records (EMR) and controls from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Princic, Nicole, Gregory, Chris, Willson, Tina, Mahue, Maya, Felici, Diana, Werther, Winifred, Lenhart, Gregory, Foley, Kathleen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081355/ https://www.ncbi.nlm.nih.gov/pubmed/27833899 http://dx.doi.org/10.3389/fonc.2016.00224

Ejemplares similares

Evaluation of the accuracy of algorithms to identify soft tissue sarcoma (STS) in administrative claims
por: Princic, Nicole, et al.
Publicado: (2020)

Development of a novel algorithm to determine adherence to chronic pain treatment guidelines using administrative claims
por: Margolis, Jay M, et al.
Publicado: (2017)

Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
por: Chari, Ajai, et al.
Publicado: (2016)

Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data
por: Marvel, Jessica, et al.
Publicado: (2019)

Validation of an algorithm for identifying MS cases in administrative health claims datasets
por: Culpepper, William J., et al.
Publicado: (2019)

Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms
por: Mathai, Stephen C., et al.
Publicado: (2019)

Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis
por: Song, Xue, et al.
Publicado: (2019)

Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data
por: Esposito, D. B., et al.
Publicado: (2019)

Validation of Claims Algorithms for Progression to Metastatic Cancer in Patients with Breast, Non-small Cell Lung, and Colorectal Cancer
por: Nordstrom, Beth L., et al.
Publicado: (2016)

Validation of Algorithms to Identify Bone Metastases Using Administrative Claims Data in a Japanese Hospital
por: Hirano, Takahiro, et al.
Publicado: (2023)

An Algorithm for the Identification of Undiagnosed COPD Cases Using Administrative Claims Data
por: Mapel, Douglas W., et al.
Publicado: (2006)

Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity
por: Dahodwala, Nabila, et al.
Publicado: (2020)

Validation of algorithms to identify colorectal cancer patients from administrative claims data of a Japanese hospital
por: Hirano, Takahiro, et al.
Publicado: (2023)

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
por: Rodríguez-Lobato, Luis Gerardo, et al.
Publicado: (2020)

Identifying Patients With Inflammatory Bowel Diseases in an Administrative Health Claims Database: Do Algorithms Generate Similar Findings?
por: Ye, Yizhou, et al.
Publicado: (2019)

Derivation and Validation of Algorithms to Identify Patients With Immunoglobulin‐G4‐Related Disease Using Administrative Claims Data
por: Wallace, Zachary S., et al.
Publicado: (2022)

An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma
por: Sharma, Ashish, et al.
Publicado: (2017)

Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis
por: Curtis, Jeffrey R, et al.
Publicado: (2011)

Predicting Diagnosis of Alzheimer’s Disease and Related Dementias Using Administrative Claims
por: Albrecht, Jennifer S., et al.
Publicado: (2018)

Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review
por: Hájek, Roman, et al.
Publicado: (2020)

Multiple Myeloma Presenting as Acute Renal Failure in the Absence of Other Characteristic Features
por: Gastelum, Zachary N, et al.
Publicado: (2017)

Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
por: Huntington, Scott F., et al.
Publicado: (2022)

Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data
por: Beyrer, Julie, et al.
Publicado: (2021)

The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw
por: Wright, Nicole C., et al.
Publicado: (2015)

Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis
por: Birt, Julie A, et al.
Publicado: (2020)

Canadian perspectives in multiple myeloma on the use of steroids in clinical practice based on patient and healthcare provider interviews
por: McKenzie, Farah, et al.
Publicado: (2022)

Accuracy of algorithms to identify patients with a diagnosis of major cancers and cancer-related adverse events in an administrative database: a validation study in an acute care hospital in Japan
por: Fujiwara, Takashi, et al.
Publicado: (2022)

Validation of claims data algorithms to identify nonmelanoma skin cancer
por: Eide, Melody J., et al.
Publicado: (2012)

Validation of a Case-Finding Algorithm for Identifying Patients with Non-small Cell Lung Cancer (NSCLC) in Administrative Claims Databases
por: Turner, Ralph M., et al.
Publicado: (2017)

Therapeutic Advancements in Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2014)

PIWIL1 Drives Chemoresistance in Multiple Myeloma by Modulating Mitophagy and the Myeloma Stem Cell Population
por: Wang, Yajun, et al.
Publicado: (2022)

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease
por: Raimondi, Vincenzo, et al.
Publicado: (2022)

Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms
por: Lee, Hemin, et al.
Publicado: (2021)

Editorial: Molecular Mechanisms of Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

4486 Assessing the Validity of an ICD-9 and ICD-10 Coding Algorithm for Identifying Cervical Premalignant Lesions Using Administrative Claims Data
por: Shing, Jaimie Zhi, et al.
Publicado: (2020)

Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?
por: D’Agostino, Mattia, et al.
Publicado: (2023)

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Current Role of Radiation Therapy for Multiple Myeloma
por: Talamo, Giampaolo, et al.
Publicado: (2015)

Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle
por: Malek, Ehsan, et al.
Publicado: (2017)

Actors on the Scene: Immune Cells in the Myeloma Niche
por: Leone, Patrizia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m29ngi1njtfq0gi5rab91mpee2